Letter to the Editor regarding 'A randomized study of 6 versus 3 years of adjuvant imatinib in patients with localized GIST at high risk of relapse' by JY Blay et al
Ann Oncol. 2024 Sep 27:S0923-7534(24)04029-8.
doi: 10.1016/j.annonc.2024.09.017.
Online ahead of print.
1 School of Integrated Chinese and Western Medicine, Zhejiang Chinese Medicine University, Hangzhou; Department of General Surgery, Tongde Hospital of Zhejiang Province, Hangzhou.
2 Department of Traditional Chinese Medicine, Community Health Service Center of Guali Town of Xiaoshan, Hangzhou, China. Electronic address: [email protected].